Γ

SynBioBeta Speaker

Maria Lence

For Women's Health

CEO & Founder

Maria Lence is the Founder and CEO of For Women’s Health, a platform dedicated to advancing women’s health by addressing the needs of both healthcare providers and the women they serve.Maria’s journey began with her personal experience navigating a complex and fragmented healthcare system. It took 5 years and consultations with 15 health providers to receive a correct diagnosis and treatment for a common hormonal imbalance—an experience that underscored a systemic issue, not a clinical one. This realization became the catalyst for applying her professional background in technology to drive meaningful change in women’s health.As an early employee in globally successful marketplaces like Booking.com, Expedia, TripAdvisor, Maria developed a deep expertise in leveraging technology to solve complex problems. She has a strong track record of growing businesses through consultative, data-driven strategies—building new revenue streams, launching business units, developing go-to-market strategies, and forging key partnerships.oblly

Sessions Featuring

Maria

This Year

Femtech

4:30 PM

-

5:15 PM

Human Health

Engineering Reproduction

From AI-powered drug discovery to genomic selection and ovarian longevity — one of the most technically complex and ethically charged frontiers in biotech.The biology of reproduction has always carried the weight of the human story. Now it carries the weight of the possible.Ovarian aging is being mapped at the molecular level. Genomic selection is moving from research settings into clinical practice. AI is accelerating drug discovery for conditions that have been chronically underfunded and chronically misunderstood. The tools exist. The data is accumulating. The ethical frameworks are being written in real time — by the scientists in this room.

Femtech

4:30 PM

-

5:15 PM

Human Health

Engineering Reproduction

From AI-powered drug discovery to genomic selection and ovarian longevity — one of the most technically complex and ethically charged frontiers in biotech.The biology of reproduction has always carried the weight of the human story. Now it carries the weight of the possible.Ovarian aging is being mapped at the molecular level. Genomic selection is moving from research settings into clinical practice. AI is accelerating drug discovery for conditions that have been chronically underfunded and chronically misunderstood. The tools exist. The data is accumulating. The ethical frameworks are being written in real time — by the scientists in this room.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include